MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
11.53
-0.18 (-1.54%)
Dec 18, 2025, 4:00 PM EST - Market closed
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $54.12 million as of December 18, 2025. Its market cap has increased by 90.07% in one year.
Market Cap
54.12M
Enterprise Value
45.57M
1-Year Change
90.07%
Ranking
Category
Stock Price
$11.53
Market Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $54.12M, a decrease of -85.99%. That is a compound annual growth rate of -37.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 54.12M | 95.97% |
| Dec 31, 2024 | 27.62M | -25.23% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
| Oct 15, 2021 | 386.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.80B |
| Johnson & Johnson | 506.75B |
| AbbVie | 396.44B |
| UnitedHealth Group | 300.40B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 246.17B |
| Abbott Laboratories | 220.33B |